Frequent exacerbations in chronic obstructive pulmonary disease

BMJ

Volumn 342, Issue 7801, 2011, Pages

  George, Christina ^a   Zermansky, Will ^b   Hurst, John R ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b Highgate Group Practice   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LONG ACTING DRUG; MUCOLYTIC AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; OXYGEN; PREDNISONE; STEROID;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DISEASE SEVERITY; HUMAN; LUNG FUNCTION; MALE; MORTALITY; OXYGEN THERAPY; PALLIATIVE THERAPY; PHYSIOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; SOCIAL SUPPORT; SPUTUM ANALYSIS; SYMPTOMATOLOGY; ACUTE DISEASE; DIFFERENTIAL DIAGNOSIS; MIDDLE AGED; RECURRENT DISEASE;

ACUTE DISEASE; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECURRENCE; SOCIAL SUPPORT;

EID: 79953869890     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d1434     Document Type: Article

References (4)

1. National Institute for Health and Clinical Excellence (NICE). Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care update guideline. 2011. http://guidance.nice.org.uk/CG101
2. Primary Care Respiratory Society UK. Diagnosis and management of COPD in primary care: a guide for those working in primary care. 2010. www.pcrs-uk.org/resources/copd-guidelinebooklet-final.pdf
3. Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;363:1128-38. www.nejm.org/doi/full/10.1056/ NEJMoa0909883
4. Drug and Therapeutics Bulletin. Preventing exacerbations in chronic obstructive pulmonary disease. BMJ 2011;342:c7207. doi: 10.1136/bmj.c7207